Cargando…
Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements
The most recent update to the International Myeloma Working Group consensus criteria places a strong emphasis on the need for more sensitive haematological markers of response driven by the success of novel therapies. One such marker is serum free light chain (sFLC) analysis, which was first incorpo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365491/ https://www.ncbi.nlm.nih.gov/pubmed/30573778 http://dx.doi.org/10.1038/s41375-018-0339-y |